About: Comorbidity and its Impact on Patients with COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comorbidity and its Impact on Patients with COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Comorbidity and its Impact on Patients with COVID-19
Creator	Altaf, Mohsin Desai, Priyank Hosein, Zaheeda Mangat, Jasmine Marinkovic, Aleksandra Okorie, Chuku Padda, Inderbir Patidar, Risha Sanyaolu, Adekunle Younis, Kokab
Source	Medline; PMC
abstract	A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan, China, in December 2019. Since then, the virus has made its way across the globe to affect over 180 countries. SARS-CoV-2 has infected humans in all age groups, of all ethnicities, both males and females while spreading through communities at an alarming rate. Given the nature of this virus, there is much still to be learned; however, we know that the clinical manifestations range from a common cold to more severe diseases such as bronchitis, pneumonia, severe acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. It is believed that COVID-19, in those with underlying health conditions or comorbidities, has an increasingly rapid and severe progression, often leading to death. This paper examined the comorbid conditions, the progression of the disease, and mortality rates in patients of all ages, infected with the ongoing COVID-19 disease. An electronic literature review search was performed, and applicable data was then collected from peer-reviewed articles published from January to April 20, 2020. From what is known at the moment, patients with COVID-19 disease who have comorbidities, such as hypertension or diabetes mellitus, are more likely to develop a more severe course and progression of the disease. Furthermore, older patients, especially those 65 years old and above who have comorbidities and are infected, have an increased admission rate into the intensive care unit (ICU) and mortality from the COVID-19 disease. Patients with comorbidities should take all necessary precautions to avoid getting infected with SARS CoV-2, as they usually have the worst prognosis.
has issue date	2020-06-25(xsd:dateTime)
bibo:doi	10.1007/s42399-020-00363-4
bibo:pmid	32838147
has license	no-cc
sha1sum (hex)	25000cd65128163365664fdc359e4f869e2c59bc
schema:url	https://doi.org/10.1007/s42399-020-00363-4
resource representing a document's title	Comorbidity and its Impact on Patients with COVID-19
has PubMed Central identifier	PMC7314621
has PubMed identifier	32838147
schema:publication	SN Compr Clin Med
resource representing a document's body	covid:25000cd65128163365664fdc359e4f869e2c59bc#body_text
is schema:about of	named entity 'rapid' named entity 'comorbid' named entity 'severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)' named entity 'progression' named entity 'RATE' named entity 'GLOBE' named entity 'COMMON COLD' named entity 'VIRUS' named entity 'INFECTED' named entity 'NOVEL' named entity 'SEVERE' named entity 'DISEASE' named entity 'DISEASES' named entity 'LEARNED' named entity 'PAPER' named entity 'COUNTRIES' named entity 'ethnicities' named entity 'ages' named entity 'leading' named entity 'infected' named entity 'learned' named entity 'multi-organ failure' named entity 'COVID-19' named entity 'acute respiratory distress syndrome' named entity 'virus' named entity 'virus' named entity 'pneumonia' named entity 'multi-organ failure' named entity 'COVID-19' named entity 'supportive measures' named entity 'chronic kidney disease' named entity 'median age' named entity 'COVID' named entity 'virus' named entity 'COVID' named entity 'transplant recipients' named entity 'lung' named entity 'chronic illnesses' named entity 'steroids' named entity 'COVID' named entity 'chills' named entity 'Coronavirus disease' named entity 'New York' named entity 'coronavirus' named entity 'blood glucose' named entity '5.2' named entity 'muscle aches' named entity 'COVID' named entity 'type 2 diabetes' named entity 'COVID' named entity 'COVID-19' named entity 'comorbidities' named entity 'cough' named entity 'renal disorders' named entity 'Beijing' named entity 'comorbidities' named entity 'COVID' named entity 'PubMed' named entity 'respiratory distress' named entity 'March 1' named entity 'etiology' named entity 'comorbidities' named entity 'comorbidity' named entity 'shortness of breath' named entity 'COVID' named entity 'public health' named entity 'glucose' named entity 'coronavirus' named entity 'Nigeria' named entity 'tested positive for COVID-19' named entity 'COVID' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software